This Biotech Stock Is Up 158% in a Year. What's Driving It Higher? [Yahoo! Finance]
Insight Molecular Diagnostics Inc. (IMDX)
Company Research
Source: Yahoo! Finance
IMDX has surged 158% over the past year and is trading at a new two-year high. Shares maintain a 100% “Buy” opinion from Barchart. Analyst sentiment is mixed, with price targets from $4 to $8. Today's Featured Stock Valued at $215 million, Insight Molecular Diagnostics (IMDX) is a precision diagnostics company. The company's tests are designed to help provide clarity and confidence to physicians and their patients. The company's flagship transplant technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). Its scientists have played a critical role in developing the science that helped establish dd-cfDNA as a trusted biomarker of transplant rejection, and iMDx is now commercializing that technology. More News from Barchart AMD Short Strangle Could Net $1400 in a Few Weeks I'm Preparing for a ‘Bang' When the Nasdaq Crashes. Here's How I'm Trading the QQQ ETF First. Amazon Just Ditched Its Stake in IonQ Stock. Should You Bail on the Q
Show less
Read more
Impact Snapshot
Event Time:
IMDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMDX alerts
High impacting Insight Molecular Diagnostics Inc. news events
Weekly update
A roundup of the hottest topics
IMDX
News
- Insight ‘congratulated' STAR working group on organ health testing paper [Yahoo! Finance]Yahoo! Finance
- IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant MonitoringGlobeNewswire
- iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation [Yahoo! Finance]Yahoo! Finance
- iMDx Announces “JPM Week” and “BTIG Snowbird” Conference ParticipationGlobeNewswire
- iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch [Yahoo! Finance]Yahoo! Finance
IMDX
Sec Filings
- 11/10/25 - Form 10-Q
- 11/10/25 - Form 8-K
- 11/4/25 - Form 4
- IMDX's page on the SEC website